Document Detail

Efficacy and safety evaluation of perindopril-lercanidipine combined therapy in patients with mild essential hypertension.
MedLine Citation:
PMID:  25424689     Owner:  NLM     Status:  Publisher    
Abstract Objective: To investigate the efficacy and safety of perindopril-lercanidipine combination versus perindopril or lercanidipine monotherapies in patients with mild essential hypertension. Methods: A total of 180 patients with mild essential hypertension were randomly assigned to three groups: group A (perindopril 2 mg plus lercanidipine 5 mg; n = 60), group B (lercanidipine 10 mg; n = 60) and group C (perindopril 4 mg; n = 60). The treatment efficacy and the incidence of adverse events were evaluated at the end of 4, 8 and 12 weeks after treatment initiation. Results: The blood pressure in group A was already lower than in group B and group C at week 4 after treatment initiation. Systolic blood pressure was 148 ± 13 mmHg in group A, 151 ± 14 mmHg in group B, and 153 ± 13 in group C (p < 0.001); diastolic blood pressure was 89 ± 8, 92 ± 7 and 92 ± 6 mmHg, respectively (p < 0.001). At the end of treatment the normalization rate was significantly higher in group A, compared with group B and group C (71.7%, 68.3%, and 48.3%, respectively; p < 0.05). Four adverse events were observed in group A, while seven and nineteen adverse events occurred in group B and in group C, respectively. Statistically significant differences in adverse reaction incidence were reported among three groups. Conclusion: Although its results were collected in an overall limited number of patients in a single center, this study shows that the combination of perindopril and lercanidipine, compared with lercanidipine alone or perindopril alone, was effective in improving blood pressure in mild essential hypertensive patients, and also decreased the incidence of adverse events.
Zhengyu Yang
Related Documents :
9922389 - Two blood pressure/cardiac mass quantitative trait loci on chromosome 3 in dahl rats.
3020089 - Chronic caffeine administration exacerbates renovascular, but not genetic, hypertension...
25277169 - Intensity-dependent reductions in resting blood pressure following short-term isometric...
8829819 - Hypertension from carotid occlusion decreases renal papillary plasma flow, hypotension ...
20645789 - Effect of myricetin on blood pressure and metabolic alterations in fructose hypertensiv...
23140349 - Pressure-tuning infrared and raman microscopy study of the dna bases: adenine, guanine,...
3209569 - Mechanics of compartmental models of the chest wall.
7223899 - Intracellular recording of in situ ventricular cells during ventricular fibrillation.
11447089 - Load versus humoral activation in the genesis of early hypertensive heart disease.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-11-26
Journal Detail:
Title:  Current medical research and opinion     Volume:  -     ISSN:  1473-4877     ISO Abbreviation:  Curr Med Res Opin     Publication Date:  2014 Nov 
Date Detail:
Created Date:  2014-11-26     Completed Date:  -     Revised Date:  2014-11-27    
Medline Journal Info:
Nlm Unique ID:  0351014     Medline TA:  Curr Med Res Opin     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-4     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intrapiriformis lipoma: an unusual cause of piriformis syndrome.
Next Document:  Variations in the popliteal artery branching in 342 patients studied with peripheral CT angiography ...